Global.hisamitsu Courses

All Time Past 24 Hours Past Week Past month

About Us|Hisamitsu Pharmaceutical Co.,inc.

  • Policy and Statement on Human Rights
  • The Hisamitsu Corporate Charter; Hisamitsu Pharmaceutical Co.,Inc
  • Human rights Policy; Modern Slavery & Human Trafficking Statement

44 people watched See more ››
Global   3 days ago   All Courses ››

Considering Global CSR|Corporate Social Responsibility

  • In-house education and training are also carried out that incorporate ideas from outside experts as part of ongoing efforts to advance the corporate mission
  • Noven’s mission to meaningfully benefit patients around the world can be fully realized only if we also act in the best interest of our communities and strive to

57 people watched . Social Sciences Courses See more ››
Global   6 days ago   All Courses ››

Stakeholders|About Us|Hisamitsu Pharmaceutical Co.,inc.

  • Employees are important stakeholders
  • We must conduct our business activities while mobilizing diverse personnel with a wide range of skills and roles
  • To do this, we must conduct management that takes into consideration employment-related issues, education and training, welfare and …

59 people watched See more ››
Global   3 days ago   All Courses ››

Overseas Network|Corporate Profile|About Us|Hisamitsu

Name of business establishments Address; Tokyo the First and the Second Branch: Tokyo, Shibuya, Sasazuka 2-1-6, Japan 151-0073: Osaka Branch: Osaka, Osaka, Chuo-ku, …

60 people watched See more ››
Global   Just Now   All Courses ››

Hisamitsu America Inc 100 Campus Dr, Florham Park, NJ

  • Category Pharmaceutical Products-Wholesale & Manufacturers Gallery
  • Be the first to add a photo! Add a Photo
  • Hi there! Be the first to review! 5 First-class 4 Better than most 3 About what I expected 2 Not the worst 1 Disappointing

54 people watched See more ››
Yellowpages   9 days ago   All Courses ››

Noven To Present Pivotal Study Results For Investigational

Noven Pharmaceuticals, Inc., ("Noven") a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced it will present the results of a multicenter, phase 2, laboratory classroom study which evaluated the safety and efficacy of its investigational dextroamphetamine transdermal system ("ATS") in over 100 pediatric patients (ages 6-17 years) with ADHD at the 2021 …

59 people watched See more ››
Ca   4 days ago   All Courses ››

Noven Submits New Drug Application For Investigational

Noven Pharmaceuticals, Inc., (“Noven”) a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today confirmed it has submitted a New Drug

55 people watched See more ››
Marketwatch   3 days ago   All Courses ››

Noven Submits New Drug Application For Investigational

  • Noven Pharmaceuticals, Inc., ("Noven") a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today confirmed it has submitted a New Drug Application (NDA) with the U.S
  • Food and Drug Administration (FDA) seeking approval to market its dextroamphetamine transdermal system ("ATS")
  • Noven’s ATS, in 4.5mg/9 hours, 9.0 mg/9 hours, 13.5mg/9 hours and 18.0mg/9 hours dosage …

55 people watched See more ››
Uk   5 days ago   All Courses ››

UAE – Market Research News

  • The global cold pain therapy market size is expected to reach USD 2.3 billion by 2026, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 4.9%
  • Rising incidence of orthopedic diseases has led to high growth of the market
  • CDC estimated that nearly 78 million people in the U.S., aged 18 years or above, are expected to be diagnosed with arthritis by 2040.

28 people watched See more ››
Industrytechnologyreports   2 days ago   All Courses ››

Cold Compression Therapy Market Size, Share Report, 2020

  • DJO Global Hisamitsu Pharmaceutical Hisamitsu Pharmaceutical Medline Industries, Inc
  • Össur Performance Health Pfizer Polar Products PowerPlay ROHTO Pharmaceutical Co., Ltd
  • Romsons Group of Industries Sanofi ThermoTek Unexo Life Sciences Pvt

58 people watched See more ››
Visiongain   1 days ago   All Courses ››

Noven To Present Pivotal Study Results For Investigational

Noven Pharmaceuticals, Inc., (“Noven”) a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced it will present the results of a

59 people watched See more ››
Marketwatch   6 days ago   All Courses ››

Hisamitsu Pharmaceutical Co., Inc., 2-4-1, Marunouchi,

  • * This phone number available for 3 min is not the recipient’s number but a number from a service which will put you through to that person
  • This service is produced by Kompass.

54 people watched See more ››
Ie   6 days ago   All Courses ››

Noven To Present Pivotal Study Results For Investigational

Noven Pharmaceuticals, Inc., (“Noven”) a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced it will present the results of a …

59 people watched See more ››
Citizentribune   8 days ago   All Courses ››

Phase III Study Results For HP-3070 (Asenapine

  • Schizophrenia is a severe, chronic psychiatric disease with a heterogeneous course and symptom profile
  • The symptoms associated with schizophrenia are …

47 people watched See more ››
Businesswire   Just Now   All Courses ››

Noven Submits New Drug Application For Investigational

  • MIAMI & JERSEY CITY, N.J.--(BUSINESS WIRE)--Noven Pharmaceuticals, Inc., (“Noven”) a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today confirmed it has submitted a New Drug Application (NDA) with the U.S
  • Food and Drug Administration (FDA) seeking approval to market its dextroamphetamine transdermal system (“ATS”).

55 people watched See more ››
Bioflorida   3 days ago   All Courses ››

SECUADO® (asenapine) Transdermal System, The First-and

Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced that SECUADO® (asenapine) transdermal sy

60 people watched See more ››
Businesswire   2 days ago   All Courses ››

Phase III Study Results For HP-3070 (Asenapine

Bloomberg the Company & Its Products The Company & its Products Bloomberg Terminal Demo Request Bloomberg Anywhere Remote Login Bloomberg Anywhere Login Bloomberg Customer Support Customer Support

47 people watched See more ››
Bloomberg   3 days ago   All Courses ››

ア メ リ カ 緬 甸 .網 COVID-19

I wrote: mochiron of course, let AntiPM10.4COVID-19 eats ꌁCOVID-19ꌁ, and ꌁCOVID-19ꌁ will disappear for sure; Remember: (, , ) We've to do air-to-air missiles alike and we must defeat COVID-19;

37 people watched See more ››
Acejaw   5 days ago   All Courses ››

Phase III Study Results For HP-3070 (Asenapine

MIAMI & JERSEY CITY, N.J.--(BUSINESS WIRE)-- Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Ltd., announced today that the primary and key secondary efficacy endpoints and safety results from the pivotal Phase III study for HP-3070 (asenapine) transdermal drug delivery system (TDDS), an investigational product for the treatment of …

47 people watched See more ››
Biospace   7 days ago   All Courses ››

Noven Announces Appointment Of Andrew J. Purcell As Head

  • Schizophrenia is a severe, chronic psychiatric disease with a heterogeneous course and symptom profile
  • The symptoms associated with schizophrenia are …

57 people watched See more ››
Businesswire   3 days ago   All Courses ››

Noven Announces Appointment Of Andrew J. Purcell As Head

  • Noven Announces Appointment of Andrew J
  • Purcell as Head of Marketing & Sales -- Key addition as Noven prepares for commercialization of HP-3070 -- …

57 people watched See more ››
Bloomberg   6 days ago   All Courses ››

Citybizlist : Philadelphia : Noven Announces Appointment

  • Schizophrenia is a severe, chronic psychiatric disease with a heterogeneous course and symptom profile
  • The symptoms associated with schizophrenia are disabling and lifelong, and greatly affect a patient’s quality of life and social functioning
  • Symptoms such as hallucinations and delusions usually start between ages 16 and 30.

57 people watched See more ››
Philadelphia   6 days ago   All Courses ››

SECUADO® (asenapine) Transdermal System, The First-and

  • MIAMI & JERSEY CITY, N.J.--(BUSINESS WIRE)--Apr 13, 2020--Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced that SECUADO ® (asenapine) transdermal system, the first-and-only transdermal patch formulation approved by the U.S
  • Food and Drug Administration (FDA) for the treatment of adults with schizophrenia, is now available by

60 people watched See more ››
Apnews   1 days ago   All Courses ››

Noven Announces Appointment Of Andrew J. Purcell As Head

  • Schizophrenia is a severe, chronic psychiatric disease with a heterogeneous course and symptom profile
  • The symptoms associated with schizophrenia are disabling and lifelong, and greatly affect a patient’s quality of life and social functioning
  • Symptoms such as hallucinations and delusions usually start between ages 16 and 30.

57 people watched See more ››
Bioflorida   Just Now   All Courses ››

Cold Pain Therapy Market Will Reach US$ 2.6 Bn By 2028

The global Cold Pain Therapy market size is expected to be worth around US$ 2.6 billion by 2028, according to a new report by Vision Research …

55 people watched See more ››
Arnnet   5 days ago   All Courses ››

Noven Announces Appointment Of Andrew J. Purcell As Head

  • Schizophrenia is a severe, chronic psychiatric disease with a heterogeneous course and symptom profile
  • The symptoms associated with schizophrenia are disabling and lifelong, and greatly affect a patient’s quality of life and social functioning
  • Symptoms such as hallucinations and delusions usually start between ages 16 and 30.

57 people watched See more ››
Biospace   6 days ago   All Courses ››

Categorical Response And Clinical Relevance As Assessed In

Categorical Response and Clinical Relevance as Assessed in a Phase III Study of HP-3070 (Asenapine) Transdermal Patch for the Treatment of Schizophrenia to be Presented at the American Psychiatric

59 people watched See more ››
Bloomberg   5 days ago   All Courses ››

Miami, FL, July 11, 2019 -- Noven Pharmaceuticals, Inc.

  • Schizophrenia is a severe, chronic psychiatric disease with a heterogeneous course and symptom profile
  • The symptoms associated with schizophrenia are disabling and lifelong, and greatly affect a patient’s quality of life and social functioning
  • Symptoms such as hallucinations and delusions usually start between ages 16 and 30.

55 people watched See more ››
Noven   1 days ago   All Courses ››

SECUADO® (asenapine) Transdermal System, The First-and

  • MIAMI & JERSEY CITY, N.J.--(BUSINESS WIRE)-- Noven Pharmaceuticals, Inc
  • a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced that SECUADO ® (asenapine) transdermal system, the first-and-only transdermal patch formulation approved by the U.S
  • Food and Drug Administration (FDA) for the treatment of adults with schizophrenia, is now available …

60 people watched See more ››
Biospace   2 days ago   All Courses ››

#Global Pharmaceutical • Raw Ranked Sites

  • Barnett International - Leaders in Clinical Research Training Superior clinical research training courses and training consulting services, since 1979
  • Barnett helps clients get the most out of their research and development dollars by managing change effectively, improving organizational performance, and enhancing staff knowledge.

43 people watched See more ››
Rawranked   8 days ago   All Courses ››

Noven To Present Pivotal Study Results For Investigational

For information about Hisamitsu, visit https://global.hisamitsu short selling for other stocks is expected to be taken later.After going through a mandatory 1.5 hour short-selling training

59 people watched See more ››
Finance   1 days ago   All Courses ››

Categorical Response And Clinical Relevance As Assessed In

  • Schizophrenia is a severe, chronic psychiatric disease with a heterogeneous course and symptom profile
  • The symptoms associated with schizophrenia are disabling and lifelong, and greatly affect a patient’s quality of life and social functioning
  • Symptoms such as hallucinations and delusions usually start between ages 16 and 30.

59 people watched See more ››
Biospace   Just Now   All Courses ››

Global.hisamitsu" Keyword Found Websites Listing Keyword

global.hisamitsu SC Johnson Professional™ Our product offering includes the Deb Skin Care range with specialist products in the field of professional skin protection and hand hygiene in the workplace, as well as well-known SC Johnson brands and innovative professional cleaners and hygiene products.

63 people watched See more ››
Keyword-suggest-tool   1 days ago   All Courses ››

Categorical Response And Clinical Relevance As Assessed In

  • Schizophrenia is a severe, chronic psychiatric disease with a heterogeneous course and symptom profile
  • The symptoms associated with schizophrenia are disabling and lifelong, and greatly affect a patient’s quality of life and social functioning
  • Symptoms such as hallucinations and 2

59 people watched See more ››
Noven   Just Now   All Courses ››

SECUADO® (asenapine) Transdermal System, The First-and

In the international, Phase 3, double-blind, placebo-controlled study, both doses of SECUADO included in the trial, 3.8 mg/24 hour and 7.6 mg/24 …

60 people watched See more ››
Benzinga   3 days ago   All Courses ››

Global Study: Cold Pain Therapy Market Growth Rate Analysis

  • The global cold pain therapy market is estimated to surpass $2,511.5 million by 2027, exhibiting a CAGR of 4.5% from 2020 to 2027
  • The report provides all-inclusive analysis of global cold pain

59 people watched See more ››
Openpr   4 days ago   All Courses ››

About global.hisamitsu courses

2021.04.27. Notification of the results of the Phase Ⅲ clinical study of HP-5070 in Japan (primary palmar hyperhidrosis treatment drug) 2021.04.08

Website: global.hisamitsu

Total: 37 New Courses

Popular Search